Collaboration

Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan

March 10, 2010

Affymax and Takeda will co-commercialize the product in the U.S.
 

Pfizer and Strides Arcolab to Collaborate on Generic Products

January 06, 2010

Pfizer commited to becoming one of the top players in the injectables market
 

Idera Pharmaceuticals Announces Termination of Asthma and Allergy Research Collaboration Agreement

November 25, 2009

Idera to Regain Full Rights to IMO-2134 (formerly QAX935)
 

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic

November 10, 2009

Bristol-Myers Squibb buys rights to RA drug for $85 million
 

Transcept Announces Plans to Reduce Expenses by Decreasing Staff

August 18, 2009

Recent Completion of Purdue U.S. License and Collaboration Agreement
 

Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)

August 03, 2009

Sumavel DosePro is expected to be commercially available in January 2010
 

Addex Achieves Second Milestone in Parkinson's Disease Collaboration With Merck & Company, Inc.

July 10, 2009

Data Confirm Non-Dopaminergic Approach to Treating Parkinson's Disease
 

MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration

July 09, 2009

Company to Suspend Development of UDB